{"nct_id":"NCT03409107","title":"Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)","status":"COMPLETED","status_verified_date":"2024-03","start_date":"2018-03-05","start_date_type":"ACTUAL","primary_completion_date":"2020-10-07","primary_completion_date_type":"ACTUAL","completion_date":"2020-10-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}